Seqens Seqens

X

Find Orbifloxacin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

MolPort-001-738-728
Also known as: 113617-63-3, Orbax, Nsc-758614, 660932tpy6, 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid, 3-quinolinecarboxylic acid, 1-cyclopropyl-7-[(3r,5s)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, rel-
Molecular Formula
C19H20F3N3O3
Molecular Weight
395.4  g/mol
InChI Key
QIPQASLPWJVQMH-DTORHVGOSA-N
FDA UNII
660932TPY6

Orbifloxacin is a fluoroquinolone antibiotic. It is marketed by Schering-Plough Animal Health and approved for certain infections in dogs.
1 2D Structure

MolPort-001-738-728

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid
2.1.2 InChI
InChI=1S/C19H20F3N3O3/c1-8-5-24(6-9(2)23-8)17-14(21)13(20)12-16(15(17)22)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6H2,1-2H3,(H,27,28)/t8-,9+
2.1.3 InChI Key
QIPQASLPWJVQMH-DTORHVGOSA-N
2.1.4 Canonical SMILES
CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)F)C(=O)C(=CN3C4CC4)C(=O)O)F
2.1.5 Isomeric SMILES
C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)F)C(=O)C(=CN3C4CC4)C(=O)O)F
2.2 Other Identifiers
2.2.1 UNII
660932TPY6
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 113617-63-3

2. Orbax

3. Nsc-758614

4. 660932tpy6

5. 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic Acid

6. 3-quinolinecarboxylic Acid, 1-cyclopropyl-7-[(3r,5s)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, Rel-

7. Ncgc00160518-01

8. Dsstox_cid_26201

9. Dsstox_rid_81432

10. Dsstox_gsid_46201

11. 1-cyclopropyl-7-((3s,5r)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

12. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic Acid

13. Smr000544203

14. Cp-104354

15. Orbifloxacin [inn]

16. Cas-113617-63-3

17. Sr-01000790054

18. Orbifloxacin [usp:inn:ban]

19. Mfcd00864858

20. Unii-660932tpy6

21. 1-cyclopropyl-7-((3r,5s)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

22. Specplus_000366

23. Cp 104354

24. Orbifloxacin (usp/inn)

25. Orbifloxacin [mi]

26. Orbax [veterinary] (tn)

27. Orbifloxacin [jan]

28. Orbifloxacin Impurity Mixture

29. Orbifloxacin [mart.]

30. Mls000766847

31. Mls001216436

32. Divk1c_006462

33. Orbifloxacin [usp-rs]

34. Schembl125116

35. Chembl295433

36. Dtxsid7046201

37. Kbio1_001406

38. Orbifloxacin [green Book]

39. Chebi:183823

40. Hms2875g03

41. Hms3264m13

42. Pharmakon1600-01503711

43. Orbifloxacin [usp Impurity]

44. Bcp18829

45. Hy-b0915

46. Rkl10078

47. Zinc3882891

48. Orbifloxacin [usp Monograph]

49. Tox21_111867

50. Nsc758614

51. S4150

52. Akos015969739

53. Tox21_111867_1

54. Ccg-213832

55. Cs-4384

56. Db11443

57. Ks-5013

58. Nsc 758614

59. Orbifloxacin 100 Microg/ml In Methanol

60. Ncgc00160518-02

61. Ncgc00160518-03

62. Ncgc00160518-04

63. 1-cyclopropyl-5,6,8-trifluoro-1,4-dihydro-7-(cis-3,5-dimethyl-1-piperazinyl)-4-oxo-quinoline-3-carboxylic Acid

64. Sbi-0207085.p001

65. Orbifloxacin 100 Microg/ml In Acetonitrile

66. O0516

67. D08299

68. D91881

69. O-2950

70. Ab00833179_04

71. Ab00833179_05

72. Orbifloxacin, Vetranal(tm), Analytical Standard

73. A803076

74. Orbifloxacin, Antibiotic For Culture Media Use Only

75. Q7100015

76. Sr-01000790054-2

77. Sr-01000790054-3

78. Brd-k63001556-001-03-9

79. Orbifloxacin, European Pharmacopoeia (ep) Reference Standard

80. Orbifloxacin, United States Pharmacopeia (usp) Reference Standard

81. 1-cyclopropyl-5,6,8-trifluoro-7-(cis-3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid

82. 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid

83. 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid

84. 1-cyclopropyl-7-(cis-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

85. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-quinoline-3-carboxylic Acid

86. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-4-ium-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate

87. 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-triluoro-4-oxoquinoline-3-carboxylic Acid

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 395.4 g/mol
Molecular Formula C19H20F3N3O3
XLogP30.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count3
Exact Mass395.14567599 g/mol
Monoisotopic Mass395.14567599 g/mol
Topological Polar Surface Area72.9 Ų
Heavy Atom Count28
Formal Charge0
Complexity691
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY